Asymptomatic bacteriuria and urinary tract infections among renal allograft recipients

Purpose of review Bacteriuria is common among renal allograft recipients. It can be categorized into asymptomatic bacteriuria (ASB) and urinary tract infection (UTI). However, in medical literature, the classifications of bacteriuria are often not clear or ASB is also classified as a UTI. This contributes to difficulties in interpretation of the incidence and risk factors of these two entities. In this review, we describe the epidemiology, risk factors, management and the impact on renal allograft function of these two entities separately according to the recent literature. Recent findings Risk factors for ASB are not completely comparable to the risk factors of UTIs. Persistent ASB has been associated with development of acute rejection and allograft pyelonephritis. The available data suggest that treatment of ASB is not very effective. Prophylaxis with trimethoprim–sulfamethoxazole does not prevent UTIs such as allograft pyelonephritis. Blood stream infections and emphysematous allograft pyelonephritis are associated with renal allograft loss. Summary ASB is the most common manifestation of bacteriuria after renal transplantation. More effective interventions are needed to prevent bacteriuria. Renal allograft recipients with persistent ASB should be closely monitored since they could be at risk for developing not only UTIs, such as allograft pyelonephritis, but also acute rejection.

[1]  D. Lorente,et al.  Extensive emphysematous pyelonephritis in a renal allograft: case report and review of literature , 2014, Transplant infectious disease : an official journal of the Transplantation Society.

[2]  B. Rutkowski,et al.  Treated asymptomatic bacteriuria during first year after renal transplantation , 2014, Transplant infectious disease : an official journal of the Transplantation Society.

[3]  F. Cosio,et al.  Impact of urinary tract infection on allograft function after kidney transplantation , 2014, Clinical transplantation.

[4]  H. Bang,et al.  Independent Risk Factors for Urinary Tract Infection and for Subsequent Bacteremia or Acute Cellular Rejection: A Single-Center Report of 1166 Kidney Allograft Recipients , 2013, Transplantation.

[5]  D. Wojciechowski,et al.  Effect of Ciprofloxacin Combined with Sulfamethoxazole-Trimethoprim Prophylaxis on the Incidence of Urinary Tract Infections After Kidney Transplantation , 2013, Transplantation.

[6]  P. Chordia,et al.  Effects of ureteral stents on risk of bacteriuria in renal allograft recipients , 2013, Transplant infectious disease : an official journal of the Transplantation Society.

[7]  N. Afonso,et al.  Recurrent urinary tract infections in kidney transplant recipients. , 2013, Transplantation proceedings.

[8]  K. Julian,et al.  Urinary Tract Infections in Solid Organ Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  E. Cordero,et al.  Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort , 2012, Transplant infectious disease : an official journal of the Transplantation Society.

[10]  A. Grant,et al.  Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antiseptic-impregnated urethral catheters (the CATHETER trial). , 2012, Health technology assessment.

[11]  E. Goldberg,et al.  Consequences of treated versus untreated asymptomatic bacteriuria in the first year following kidney transplantation: retrospective observational study , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[12]  A. Ingsathit,et al.  High incidence of bacteriuria in early post-kidney transplantation; results from a randomized controlled study. , 2012, Transplantation proceedings.

[13]  T. Berney,et al.  Outcome of treated and untreated asymptomatic bacteriuria in renal transplant recipients. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  U. Gafter,et al.  Antibiotic prophylaxis for urinary tract infections in renal transplant recipients: a systematic review and meta‐analysis , 2011, Transplant infectious disease : an official journal of the Transplantation Society.

[15]  W. Kremers,et al.  Impact of Gram-Negative Bloodstream Infection on Long-Term Allograft Survival After Kidney Transplantation , 2011, Transplantation.

[16]  J. Morales,et al.  Acute graft pyelonephritis in renal transplant recipients: incidence, risk factors and long-term outcome. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  D. Assimos,et al.  Renal allograft failure due to emphysematous pyelonephritis: successful non‐operative management and proposed new classification scheme based on literature review , 2010, Transplant infectious disease : an official journal of the Transplantation Society.

[18]  J. Morales,et al.  Systematic screening and treatment of asymptomatic bacteriuria in renal transplant recipients. , 2010, Kidney international.

[19]  S. Vimont,et al.  Acute Pyelonephritis Represents a Risk Factor Impairing Long‐Term Kidney Graft Function , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  G. John,et al.  Acute graft pyelonephritis following renal transplantation , 2006, Transplant infectious disease : an official journal of the Transplantation Society.